SEC ownership of HEALTHEQUITY, INC.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001428336.

Comparable stake leader

WASATCH ADVISORS LP

Disclosed value leader

BlackRock, Inc.

Comparable rows

50/50

Latest evidence

10 Jul 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
WASATCH ADVISORS LP
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
10 Jul 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001428336
Issuer location
Draper, UT

Ownership snapshot

Top shareholders of HEALTHEQUITY, INC. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
WASATCH ADVISORS LP
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
10 Jul 2026
13D/G 13F 3/4/5 Lead comparable stake: 9.5% 13D/G row: WASATCH ADVISORS LP Showing 1-8 of 50 holder rows.

Quick read

WASATCH ADVISORS LP leads the comparable SEC ownership view at 9.5%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WASATCH ADVISORS LP's linked filing trail.
Comparable ownership Top 5
WASATCH ADVISORS LP 9.5%
VANGUARD CAPITAL MANAGEMENT LLC 5.3%
VANGUARD PORTFOLIO MANAGEMENT LLC 4.9%
FMR LLC 4.1%
Jon Kessler 0.39%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
WASATCH ADVISORS LP
13D/G 13F
Company
9.5%
$719,013,585
7,960,735 shares
$0 30 Jun 2026
VANGUARD CAPITAL MANAGEMENT LLC
13D/G 13F
Vanguard Capital Management · Company
5.3%
$374,324,237
4,479,170 shares
$0 31 Mar 2026
VANGUARD PORTFOLIO MANAGEMENT LLC
13D/G 13F
Vanguard Portfolio Management · Company
4.9%
$391,987,151
4,137,941 shares
-$9,372,397 30 Jun 2026
FMR LLC
13D/G 13F
Company
4.1%
$330,726,570
3,489,781 shares
$0 30 Sep 2025
Jon Kessler
3/4/5
Former Director
0.39%
$37,071,827
328,510 shares
06 Jun 2025
Scott Cutler
3/4/5
President and CEO, Director
0.21%
$15,932,899
176,405 shares
08 Jul 2026
James M. Lucania
3/4/5
EVP & CFO
0.12%
$9,449,007
104,617 shares
08 Jul 2026
Delano Ladd
3/4/5
EVP, General Counsel
0.11%
$8,133,677
90,054 shares
-$1,676,672 08 Jul 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$4,604,391.

Buys
$0
Insiders: 0
Sells
$4,604,391
Insiders: 5
Net
-$4,604,391
Shares: -48,945
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 48,945
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 17,905 $0 $1,651,280 -$1,651,280
3-6 0 0 $0 $0 $0
6-9 0 18,298 $0 $1,770,341 -$1,770,341
9-12 0 12,742 $0 $1,182,770 -$1,182,770

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 28 reporting-owner rows connected to HEALTHEQUITY, INC.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
28
Largest Forms 3/4/5 holder
Jon Kessler
Net 12M change
-$4,604,391
Latest report
10 Jul 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Jon Kessler Former Director $37,071,827 Filing P/S 06 Jun 2025
Stephen Neeleman FOUNDER AND VICE CHAIRMAN, Director $33,942,164 Mixed 08 Jul 2026
Scott Cutler President and CEO, Director $15,932,899 Median 08 Jul 2026
James M. Lucania Evp & Cfo $9,449,007 Median 08 Jul 2026
Delano Ladd EVP, General Counsel $8,133,677 -$1,676,672 -17% Median 08 Jul 2026
Ian Sacks Former Director $7,674,100 Mixed 19 Dec 2023
Robert W. Selander Director $7,508,680 Mixed 25 Jun 2026
Elimelech Rosner Evp, Chief Technology Officer $6,810,687 -$1,046,090 -13% Mixed 06 Apr 2026
Darcy G. Mott Special Advisor $6,373,640 Mixed 20 Sep 2021
Dillon Adrian T. Director $5,577,516 Mixed 25 Jun 2026
Michael Henry Fiore Evp, Chief Commercial Officer $4,963,180 -$913,872 -16% Filing P/S 10 Jul 2026
Evelyn S. Dilsaver Director $4,632,339 -$322,916 -6.5% Mixed 25 Jun 2026
Tyson D. Murdock Former Cfo $4,545,590 Mixed 28 Dec 2023
Edward Bloomberg Chief Operating Officer $4,189,500 Mixed 01 Aug 2022
Michael Gathright Chief Customer Officer $3,603,135 Median 09 Jul 2026
Larry L. Trittschuh Former Evp Cso $3,234,700 Mixed 21 Sep 2023
Slim Aissi Evp, Chief Security Officer $3,032,959 Mixed 27 Mar 2024
Gayle Furgurson Wellborn Director $2,560,606 -$644,841 -20% Mixed 25 Jun 2026
Stuart B. Parker Director $2,170,730 Mixed 25 Jun 2026
William Robert Otten Former Executive VP of Sales $2,139,620 Mixed 01 Nov 2021

Recent insider transactions for HEALTHEQUITY, INC.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Michael Henry Fiore HQY Common Stock Sale -4.31% $223,630 $95.00 -2,354 52,244 10 Jul 2026 Direct
Michael Gathright HQY Common Stock Tax liability -5.38% -2,270 39,893 09 Jul 2026 Direct
Stephen Neeleman HQY Common Stock Tax liability -0.8% -1,103 137,565 08 Jul 2026 Direct
James M. Lucania HQY Common Stock Tax liability -2.64% -2,839 104,617 08 Jul 2026 Direct
Delano Ladd HQY Common Stock Tax liability -1.19% -1,087 90,054 08 Jul 2026 Direct
Scott Cutler HQY Common Stock Tax liability -0.7% -1,238 176,405 08 Jul 2026 Direct
Michael Henry Fiore HQY Common Stock Tax liability -3.61% -2,045 54,598 08 Jul 2026 Direct
Michael Henry Fiore HQY Common Stock Sale -4.18% $234,650 $95.00 -2,470 56,643 02 Jul 2026 Direct
William Gassen HQY Common Stock Award 392% 2,877 3,611 25 Jun 2026 Direct
Rajesh Natarajan HQY Common Stock Award 18.9% 2,877 18,130 25 Jun 2026 Direct
Debra Charlotte McCowan HQY Common Stock Award 29.4% 2,877 12,659 25 Jun 2026 Direct
Stuart B. Parker HQY Common Stock Award 12.5% 2,877 25,975 25 Jun 2026 Direct
Gayle Furgurson Wellborn HQY Common Stock Award 14.6% 2,877 22,610 25 Jun 2026 Direct
Dillon Adrian T. HQY Common Stock Award 4.83% 2,877 62,395 25 Jun 2026 Direct
Evelyn S. Dilsaver HQY Common Stock Award 5.97% 2,877 51,085 25 Jun 2026 Direct
Robert W. Selander HQY Common Stock Award 3.31% 2,877 89,849 25 Jun 2026 Direct
Michael Henry Fiore HQY Common Stock Sale -5.05% $298,490 $95.00 -3,142 59,113 29 May 2026 Direct
Gayle Furgurson Wellborn HQY Common Stock Sale -11% $219,510 $90.00 -2,439 19,733 28 May 2026 Direct
Gayle Furgurson Wellborn HQY Common Stock Options Exercise 12.4% 2,439 22,172 28 May 2026 Direct
Gayle Furgurson Wellborn HQY Stock Option (right to buy) Options Exercise -100% -2,439 0 28 May 2026 Direct
Delano Ladd HQY Common Stock Sale -7.6% $675,000 $90.00 -7,500 91,141 28 May 2026 Direct
Stephen Neeleman HQY Common Stock Tax liability -1.81% -2,559 138,668 06 Apr 2026 Direct
Delano Ladd HQY Common Stock Tax liability -2.45% -2,481 98,641 06 Apr 2026 Direct
Michael Henry Fiore HQY Common Stock Tax liability -5.15% -3,378 62,255 06 Apr 2026 Direct
Elimelech Rosner HQY Common Stock Tax liability -5.53% -4,768 81,497 06 Apr 2026 Direct
James M. Lucania HQY Common Stock Tax liability -3.93% -4,393 107,456 06 Apr 2026 Direct
Scott Cutler HQY Common Stock Tax liability -2.7% -4,931 177,643 06 Apr 2026 Direct
Delano Ladd HQY Common Stock Tax liability -7,726 $101,122 31 Mar 2026 Direct
Stephen Neeleman HQY Common Stock Tax liability -6.17% -9,292 141,227 31 Mar 2026 Direct
Elimelech Rosner HQY Common Stock Tax liability -17.3% -18,010 86,265 31 Mar 2026 Direct
Delano Ladd HQY Common Stock Award 48.6% 35,608 108,848 25 Mar 2026 Direct
Michael Gathright HQY Common Stock Award 56.1% 15,157 42,163 25 Mar 2026 Direct
Stephen Neeleman HQY Common Stock Award 35.9% 39,775 150,519 25 Mar 2026 Direct
Michael Henry Fiore HQY Common Stock Award 36.6% 17,582 65,633 25 Mar 2026 Direct
Elimelech Rosner HQY Common Stock Award 138.8% 60,607 104,275 25 Mar 2026 Direct
James M. Lucania HQY Common Stock Award 32.3% 27,283 111,849 25 Mar 2026 Direct
Scott Cutler HQY Common Stock Award 66.2% 72,754 182,574 25 Mar 2026 Direct
Stuart B. Parker HQY Common Stock Award 5.78% 1,263 23,098 02 Feb 2026 Direct
Rajesh Natarajan HQY Common Stock Award 6.84% 976 15,253 02 Feb 2026 Direct
Scott Cutler HQY Common Stock Tax liability -10.2% -12,496 109,820 12 Jan 2026 Direct
Michael Henry Fiore HQY Common Stock Tax liability -3.5% -1,744 48,051 09 Jan 2026 Direct
James M. Lucania HQY Common Stock Tax liability -2.84% -2,470 84,566 09 Jan 2026 Direct
Elimelech Rosner HQY Common Stock Tax liability -4.53% -2,074 43,668 09 Jan 2026 Direct
Stephen Neeleman HQY Common Stock Tax liability -0.71% -791 110,744 09 Jan 2026 Direct
Delano Ladd HQY Common Stock Tax liability -1% -739 73,240 09 Jan 2026 Direct
Stephen Neeleman HQY Common Stock Gift 140,000 140,000 19 Dec 2025 See footnote
Stephen Neeleman HQY Common Stock Gift -25.5% -140,000 409,735 19 Dec 2025 See footnote
Delano Ladd HQY Common Stock Sale -1.99% $142,080 $94.72 -1,500 73,979 19 Dec 2025 Direct
Elimelech Rosner HQY Common Stock Sale -19.3% $1,046,090 $95.45 -10,959 45,742 18 Dec 2025 Direct
Stephen Neeleman HQY Common Stock Gift -0.09% -500 549,735 17 Dec 2025 See footnote
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .